Literature DB >> 21148472

Muscle oxidative capacity during IL-6-dependent cancer cachexia.

James P White1, Kristen A Baltgalvis, Melissa J Puppa, Shuichi Sato, John W Baynes, James A Carson.   

Abstract

Many diseases are associated with catabolic conditions that induce skeletal muscle wasting. These various catabolic states may have similar and distinct mechanisms for inducing muscle protein loss. Mechanisms related to muscle wasting may also be related to muscle metabolism since glycolytic muscle fibers have greater wasting susceptibility with several diseases. The purpose of this study was to determine the relationship between muscle oxidative capacity and muscle mass loss in red and white hindlimb muscles during cancer cachexia development in the Apc(Min/+) mouse. Gastrocnemius and soleus muscles were excised from Apc(Min/+) mice at 20 wk of age. The gastrocnemius muscle was partitioned into red and white portions. Body mass (-20%), gastrocnemius muscle mass (-41%), soleus muscle mass (-34%), and epididymal fat pad (-100%) were significantly reduced in severely cachectic mice (n = 8) compared with mildly cachectic mice (n = 6). Circulating IL-6 was fivefold higher in severely cachectic mice. Cachexia significantly reduced the mitochondrial DNA-to-nuclear DNA ratio in both red and white portions of the gastrocnemius. Cytochrome c and cytochrome-c oxidase complex subunit IV (Cox IV) protein were reduced in all three muscles with severe cachexia. Changes in muscle oxidative capacity were not associated with altered myosin heavy chain expression. PGC-1α expression was suppressed by cachexia in the red and white gastrocnemius and soleus muscles. Cachexia reduced Mfn1 and Mfn2 mRNA expression and markers of oxidative stress, while Fis1 mRNA was increased by cachexia in all muscle types. Muscle oxidative capacity, mitochondria dynamics, and markers of oxidative stress are reduced in both oxidative and glycolytic muscle with severe wasting that is associated with increased circulating IL-6 levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148472      PMCID: PMC3043802          DOI: 10.1152/ajpregu.00300.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  61 in total

Review 1.  Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes.

Authors:  Antonio Zorzano; Marc Liesa; Manuel Palacín
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

2.  Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome.

Authors:  Vibe Skov; Dorte Glintborg; Steen Knudsen; Thomas Jensen; Torben A Kruse; Qihua Tan; Klaus Brusgaard; Henning Beck-Nielsen; Kurt Højlund
Journal:  Diabetes       Date:  2007-06-11       Impact factor: 9.461

3.  The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle.

Authors:  Peter J Adhihetty; Giulia Uguccioni; Lotte Leick; Juan Hidalgo; Henriette Pilegaard; David A Hood
Journal:  Am J Physiol Cell Physiol       Date:  2009-05-13       Impact factor: 4.249

4.  Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients.

Authors:  L Puente-Maestu; J Pérez-Parra; R Godoy; N Moreno; A Tejedor; F González-Aragoneses; J-L Bravo; F Villar Alvarez; S Camaño; A Agustí
Journal:  Eur Respir J       Date:  2009-01-07       Impact factor: 16.671

5.  Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Peña; J Mark Davis; James P White; James A Carson
Journal:  Pflugers Arch       Date:  2008-08-19       Impact factor: 3.657

6.  mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex.

Authors:  John T Cunningham; Joseph T Rodgers; Daniel H Arlow; Francisca Vazquez; Vamsi K Mootha; Pere Puigserver
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

7.  Carbonic anhydrase III and four-and-a-half LIM protein 1 are preferentially oxidized with muscle unloading.

Authors:  Chiao-nan Chen; Deborah A Ferrington; LaDora V Thompson
Journal:  J Appl Physiol (1985)       Date:  2008-08-28

8.  Interleukin-6 and cachexia in ApcMin/+ mice.

Authors:  Kristen A Baltgalvis; Franklin G Berger; Maria Marjorette O Pena; J Mark Davis; Stephanie J Muga; James A Carson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-12-05       Impact factor: 3.619

9.  Fiber type-specific nitric oxide protects oxidative myofibers against cachectic stimuli.

Authors:  Zengli Yu; Ping Li; Mei Zhang; Mark Hannink; Jonathan S Stamler; Zhen Yan
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

10.  Mitochondrial fusion is increased by the nuclear coactivator PGC-1beta.

Authors:  Marc Liesa; Bárbara Borda-d'Agua; Gema Medina-Gómez; Christopher J Lelliott; José Carlos Paz; Manuel Rojo; Manuel Palacín; Antonio Vidal-Puig; Antonio Zorzano
Journal:  PLoS One       Date:  2008-10-31       Impact factor: 3.240

View more
  70 in total

Review 1.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

2.  High-Frequency Stimulation on Skeletal Muscle Maintenance in Female Cachectic Mice.

Authors:  Shuichi Sato; Song Gao; Melissa J Puppa; Matthew C Kostek; L Britt Wilson; James A Carson
Journal:  Med Sci Sports Exerc       Date:  2019-09       Impact factor: 5.411

Review 3.  Interleukin 6 as a key regulator of muscle mass during cachexia.

Authors:  James A Carson; Kristen A Baltgalvis
Journal:  Exerc Sport Sci Rev       Date:  2010-10       Impact factor: 6.230

4.  The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6.

Authors:  Brandon N VanderVeen; Dennis K Fix; Ryan N Montalvo; Brittany R Counts; Ashley J Smuder; E Angela Murphy; Ho-Jin Koh; James A Carson
Journal:  Exp Physiol       Date:  2019-01-15       Impact factor: 2.969

5.  Quercetin supplementation attenuates the progression of cancer cachexia in ApcMin/+ mice.

Authors:  Kandy T Velázquez; Reilly T Enos; Aditi A Narsale; Melissa J Puppa; J Mark Davis; E Angela Murphy; James A Carson
Journal:  J Nutr       Date:  2014-04-23       Impact factor: 4.798

6.  Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.

Authors:  Daria Neyroud; Rachel L Nosacka; Andrew R Judge; Russell T Hepple
Journal:  J Muscle Res Cell Motil       Date:  2019-04-03       Impact factor: 2.698

7.  PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia.

Authors:  Fabrizio Pin; Leah J Novinger; Joshua R Huot; Robert A Harris; Marion E Couch; Thomas M O'Connell; Andrea Bonetto
Journal:  FASEB J       Date:  2019-03-20       Impact factor: 5.191

8.  Electrical stimulation prevents doxorubicin-induced atrophy and mitochondrial loss in cultured myotubes.

Authors:  Blas A Guigni; Dennis K Fix; Joseph J Bivona; Bradley M Palmer; James A Carson; Michael J Toth
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

9.  Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia.

Authors:  Maria Lima; Shuichi Sato; Reilly T Enos; John W Baynes; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2013-01-17

10.  Eccentric contraction-induced myofiber growth in tumor-bearing mice.

Authors:  Justin P Hardee; Joshua E Mangum; Song Gao; Shuichi Sato; Kimbell L Hetzler; Melissa J Puppa; Dennis K Fix; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.